X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
anacetrapib (161) 161
index medicus (128) 128
humans (113) 113
cholesterol ester transfer proteins - antagonists & inhibitors (83) 83
torcetrapib (68) 68
coronary-heart-disease (64) 64
pharmacology & pharmacy (63) 63
animals (54) 54
dalcetrapib (51) 51
high-density-lipoprotein (48) 48
ester transfer protein (46) 46
high-risk (40) 40
male (40) 40
atherosclerosis (39) 39
cholesteryl ester transfer protein (39) 39
anticholesteremic agents - therapeutic use (34) 34
cetp inhibitor (33) 33
cholesterol, hdl - blood (33) 33
anticholesteremic agents - pharmacology (30) 30
cardiac & cardiovascular systems (30) 30
cholesterol (30) 30
lipids (30) 30
cholesterol, ldl - blood (29) 29
female (28) 28
oxazolidinones - pharmacology (28) 28
cardiovascular disease (27) 27
cetp (27) 27
evacetrapib (27) 27
hdl (26) 26
middle aged (26) 26
oxazolidinones - therapeutic use (26) 26
risk factors (25) 25
cholesterol ester transfer proteins - metabolism (24) 24
double-blind (24) 24
dyslipidemias - drug therapy (24) 24
low density lipoproteins (24) 24
statins (24) 24
dyslipidemia (23) 23
biochemistry & molecular biology (22) 22
drug therapy (22) 22
cardiovascular diseases (21) 21
cardiovascular diseases - prevention & control (21) 21
blood-pressure (20) 20
health aspects (20) 20
safety (20) 20
dosage and administration (19) 19
hdl cholesterol (19) 19
peripheral vascular disease (19) 19
adult (18) 18
coronary heart disease (18) 18
metabolism (18) 18
healthy-subjects (17) 17
ldl cholesterol (17) 17
anticholesteremic agents - adverse effects (16) 16
apolipoprotein-a-i (16) 16
cardiovascular (16) 16
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (16) 16
pharmacokinetics (16) 16
research (16) 16
treatment outcome (16) 16
aged (15) 15
cetp inhibitors (15) 15
lipoproteins (15) 15
quinolines - pharmacology (15) 15
blood cholesterol (14) 14
cholesterol, hdl - drug effects (14) 14
density-lipoprotein cholesterol (14) 14
double-blind method (14) 14
hypolipidemic agents - therapeutic use (14) 14
analysis (13) 13
drug therapy, combination (13) 13
hdl-cholesterol (13) 13
oxazolidinones - adverse effects (13) 13
prevention (13) 13
reverse cholesterol transport (13) 13
young adult (13) 13
anticholesteremic agents - pharmacokinetics (12) 12
chemistry, medicinal (12) 12
cholesterol, hdl - metabolism (12) 12
clinical trials (12) 12
low density lipoprotein (12) 12
oxazolidinones - pharmacokinetics (12) 12
care and treatment (11) 11
cetp inhibition (11) 11
dose-response relationship, drug (11) 11
drug design (11) 11
physiological aspects (11) 11
quinolines - therapeutic use (11) 11
type-2 diabetes-mellitus (11) 11
abridged index medicus (10) 10
cholesterol ester transfer proteins - blood (10) 10
clinical trials as topic (10) 10
dyslipidemias - blood (10) 10
hypercholesterolemia (10) 10
inhibitor (10) 10
randomized controlled-trial (10) 10
risk (10) 10
structure-activity relationship (10) 10
apolipoproteins (9) 9
atherosclerosis - prevention & control (9) 9
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (163) 163
Spanish (4) 4
French (2) 2
Chinese (1) 1
Czech (1) 1
German (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 12/2010, Volume 363, Issue 25, pp. 2406 - 2415
Journal Article
Journal of Lipid Research, ISSN 0022-2275, 2018, Volume 59, Issue 12, pp. 2397 - 2402
Elevated lipoprotein (a) [Lp(a)] levels increase the risk for CVD. Novel treatments that decrease LDL cholesterol (LDL-C) have also shown promise for reducing... 
ApoB antisense treatment | Fractional clearance rate | Production rate | CLEARANCE | TRANSFER PROTEIN-INHIBITION | production rate | BIOCHEMISTRY & MOLECULAR BIOLOGY | apoB antisense treatment | DENSITY | ANACETRAPIB | REDUCTION | LDL | GENETICS | PCSK9 INHIBITION | DISEASE | fractional clearance rate | LP(A) | Index Medicus
Journal Article
Journal of Cardiovascular Pharmacology and Therapeutics, ISSN 1074-2484, 11/2014, Volume 19, Issue 6, pp. 543 - 549
Journal Article
Intervencni a Akutni Kardiologie, ISSN 1213-807X, 2018, Volume 17, Issue 4, pp. 239 - 242
Journal Article
Journal of Lipid Research, ISSN 0022-2275, 12/2010, Volume 51, Issue 12, pp. 3443 - 3454
Journal Article
Current Clinical Pharmacology, ISSN 1574-8847, 11/2011, Volume 6, Issue 4, pp. 227 - 235
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 12/2018, Volume 58, Issue 12, pp. 1578 - 1585
Anacetrapib is a cholesteryl ester transfer protein inhibitor intended for the treatment of dyslipidemia. A phase 1 study was conducted to examine the... 
anacetrapib | pharmacokinetics | race | pharmacodynamics | PROTEIN CETP INHIBITOR | THERAPY | VOLUNTEERS | PHARMACOLOGY & PHARMACY | SINGLE-DOSE PHARMACOKINETICS | SIMVASTATIN | CHOLESTERYL | Proteins | Rabbits | Pharmacodynamics | Dyslipidemia | Race | Attenuation | Lipids | Pharmacology | Pharmacokinetics | Density | Cholesterol | Cholesteryl ester transfer protein | Index Medicus
Journal Article
Dialogues in Cardiovascular Medicine, ISSN 1272-9949, 2017, Volume 22, Issue 3, pp. 17 - 18
Journal Article
Journal Article
Journal Article
Angewandte Chemie International Edition, ISSN 1433-7851, 06/2013, Volume 52, Issue 24, pp. 6196 - 6201
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 09/2017, Volume 37, Issue 9, pp. 1770 - 1775
Journal Article
Journal Article